Poison Pill Defense
A Poison Pill Defense is a shareholder rights plan adopted by a company's board that allows existing shareholders to purchase additional shares at a steep discount if a hostile acquirer accumulates stock beyond a set ownership threshold, diluting the acquirer's stake and making a takeover prohibitively expensive.
The poison pill was invented in the early 1980s by corporate attorney Martin Lipton as a response to hostile takeover waves. The standard structure — called a flip-in pill — grants existing shareholders (excluding the triggering acquirer) the right to buy new shares at a 50% discount to market price once any single entity crosses a defined ownership threshold, typically 10% to 20% of outstanding shares. The resulting dilution can double the number of shares outstanding, making the cost of completing a takeover dramatically higher.
Poison pills do not require shareholder approval to adopt; boards can implement them unilaterally under the Delaware General Corporation Law (where most US public companies are incorporated). Courts have upheld the legality of pills, provided they are not deployed simply to entrench management against all outside pressure.
The modern pill has evolved into two variants. The traditional shareholder rights plan triggers on passive ownership accumulation and is aimed at hostile acquirers seeking to acquire full control. The activist pill (or wolf-pack pill) is a newer variant with a lower threshold (sometimes 5%) designed to prevent coordinated activist investors from accumulating shares together before publicly disclosing their combined stake.
Proxy advisory firms such as ISS recommend that shareholders vote against boards that maintain pills for extended periods without a shareholder vote, viewing long-lived pills as an entrenchment device. Many companies adopt pills with sunset provisions that expire after 12 to 18 months unless renewed by a shareholder vote.
During the COVID-19 market dislocation, dozens of US companies adopted pills to protect against opportunistic takeover attempts at depressed valuations, illustrating that the pill remains a live defensive tool even in the modern governance environment.